Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin-

Details Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin- Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin-

1999-02-18

2000-11-28

Celsa, Bennett

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 19, 530331, A61K 3806, C07K 500

Patent

active

061535885

ABSTRACT:
The invention is directed to a non-hygroscopic stable crystalline form of the antithrombotic compound N-[N-[N-(4-piperdin-4-yl)butanoyl)-N-ethylglycyl]-(L)-aspartyl]-(L)-.beta. -cyclohexyl-alanine amide, to processes for preparing said stable crystalline form, to a pharmaceutical composition thereof, and intermediates thereof, and the invention is directed also to processes for preparing a compound of the formula ##STR1## wherein: A, B, Z, E.sup.1, E.sup.2, G, R, m, n, and p are as defined herein.

REFERENCES:
patent: 5064814 (1991-11-01), Klein et al.
patent: 5340798 (1994-08-01), Nutt et al.
patent: 5607948 (1997-03-01), Ikeda et al.
patent: 5707994 (1998-01-01), Ikeda et al.
patent: 5780590 (1998-07-01), Klein et al.

Affiliated with

Also associated with

Rating

Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin- will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1725934